← Back to all trials
Not Yet Recruiting
NCT07731529
Vivifrail Exercise Program in Nonagenarians: Effects on Function, Muscle, and Cognition
Conditions: Frailty, Aging, Cognitive Decline
Sex: All
Ages: 90 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 54
Sponsor: Federal University of Rio Grande do Sul
Location: Hospital de Clínicas de Porto Alegre (HCPA) - Geriatrics outpatient clinic Porto Alegre Rio Grande do Sul
Summary
This randomized clinical trial investigates the effects of a home-based multicomponent exercise program (Vivifrail) on physical function, muscle morphology, and cognition in community-dwelling adults aged 90 years and older. Participants are randomized into three groups: Vivifrail at least twice a week, Vivifrail at least three times a week, or a control group. Outcomes are assessed at baseline, 12 weeks, and 24 weeks. The primary outcome is physical function measured by the Short Physical Performance Battery (SPPB).
Eligibility Criteria
Inclusion Criteria:
* Aged 90 years or older
* Living in the community (own or family home)
* Able to walk independently or with a walking aid (cane or walker), without third-party assistance
* Minimum cognitive capacity to understand and perform the exercises (MMSE, education-adjusted cutoffs)
* Adequate home conditions to perform the program
* Availability of a family member or caregiver to support the sessions
* Signed informed consent (with legal guardian assistance when needed)
Exclusion Criteria:
* \- Total inability to walk or permanent bedridden condition
* Severe cognitive impairment preventing safe understanding and execution of exercises
* Severe orthopedic, neurological, or rheumatological conditions preventing exercise
* Concurrent participation in another structured exercise program
* Anticipated unavailability (relocation, planned hospitalization, or institutionalization) during the intervention
* Refusal to sign informed consent or absence of a legal guardian when required
Source: ClinicalTrials.gov (NCT07731529). StuddyBuddy aggregates publicly available trial information.